Videos
Advanced Ovarian Cancer
HER2+ BC: Residual Disease After Neoadjuvant Therapy
Bassel El-Rayes, MD, discusses the key points physicians should consider when treating a patient with metastatic colorectal cancer.
Early HER2+ Breast Cancer
Multiple Myeloma
Noopur Raje, MD, discusses the current treatment options for patients diagnosed with multiple myeloma. At this time, a number of FDA-approved drugs and different combinations are available.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Telehealth May Offer a Path to More Equitable Myeloma Transplant Access
2
FDA Application Withdrawn for I-DXd in Small Cell Lung Cancer
3
Zabilugene Almadenorepvec Plus Chemo Shows Survival Gains in Metastatic PDAC
4
Oral Azacitidine-Cedazuridine Meets Pharmacokinetic Goal in Phase 3 MDS/CMML Trial
5